ProPhase Labs Inc

PRPH 7.66
0.06 (0.8%)

Open: 7.79 High: 8.00 Low: 7.43

9 x 7.66 = 68.94

Shares

Total

NASDAQ: PRPH $120 Million Small-Cap. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 555%. 1 Year Return 314%. 2021 YTD Return 28%. Since Earnings 10%.

ST

External Links

Charts

52WL $1.20

The 52 Week Low is $1.20 set on Fri, Jun 26, 2020.

52WH $16.04

The 52 Week High is $16.04 set on Fri, Jan 15, 2021.

ATH $16.04

The All-Time High is $16.04 set on Fri, Jan 15, 2021.

52 Week Range

$1.20

$16.04

Jun 26, 2020

Jan 15, 2021

Earnings

-0.04

Earnings Per Share

0.00

Price To Earnings Ratio

Q2 Earnings for Apr, May & Jun

Tue, Aug 11, 2020

Since Q2 Earnings Report

PRPH 294.9%

Q3 Earnings for Jul, Aug & Sep

Mon, Nov 16, 2020

Since Q3 Earnings Report

PRPH 10.2%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

Wed, Jan 9, 2019

Ex-Dividend Date

Thu, Jan 24, 2019

Dividend Payment Date

--

Dividend Frequency

2

Dividend History

Profile

ProPhase Labs Inc trades on the NASDAQ. PRPH's market cap is 120.00 Million.

ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health.

Website